SCHEMBL17079652

SCHEMBL17079652

CC(C)(C(=O)O)c1ccc(O)c(O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
HPGD P15428 3/20 0.59
ALOX15 P16050 3/20 0.59
HSD17B10 Q99714 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
SIRT1 Q96EB6 1/20 0.50
KDM4E B2RXH2 3/20 0.47
POLB P06746 3/20 0.47
MAPT P10636 3/20 0.47
CYP1A2 P05177 2/20 0.47
CYP3A4 P08684 2/20 0.47
GAA P10253 2/20 0.47
PTGS2 P35354 2/20 0.47
FYN P06241 2/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
EGFR P00533 1/20 0.47
APEX1 P27695 1/20 0.47
ADRA1A P35348 1/20 0.47
MTOR P42345 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30319438 1.00 ALDH1A1 (0.59) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL16189491 0.86 ESR1 (0.61) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL17504871 0.82 APP (0.43) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL31292258 0.82 APP (0.58) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL29531941 0.82 ALDH1A1 (0.57) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL22619519 0.82 ALDH1A1 (0.57) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL10483821 0.82 ALDH1A1 (0.57) ALDH1A1HPGDALOX15HSD17B10TDP1
Hydrogen Peroxide SCHEMBL28263775 0.82 ALDH1A1 (0.57) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL1805555 0.82 ALDH1A1 (0.57) ALDH1A1HPGDALOX15HSD17B10TDP1
SCHEMBL11552788 0.81 HSP90AA1 (0.44) ALDH1A1HPGDALOX15HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250073193-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2025-03-06 US claimed
EP-4299128-A2 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS Neuroderm Ltd. (IL) 2024-01-03 EP claimed
EP-3777833-B1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2023-10-18 EP claimed
US-20230096364-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2023-03-30 US claimed
EP-3777833-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS Neuroderm Ltd (IL) 2021-02-17 EP claimed
US-20210000777-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2021-01-07 US claimed
EP-3116475-B1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2020-11-04 EP claimed
US-10813902-B2 DOPA decarboxylase inhibitor compositions NEURODERM, LTD. (IL) 2020-10-27 US claimed
US-10624839-B2 Dopa decarboxylase inhibitor compositions NEURODERM, LTD. (IL) 2020-04-21 US claimed
US-20200046665-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2020-02-13 US claimed
US-20190151233-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM, LTD. (IL) 2019-05-23 US claimed
US-10258585-B2 DOPA decarboxylase inhibitor compositions NEURODERM, LTD. (IL) 2019-04-16 US claimed
US-10022320-B2 Dopa decarboxylase inhibitor compositions NEURODERM, LTD. (IL) 2018-07-17 US claimed
US-20170157079-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM, LTD. (IL) 2017-06-08 US claimed
EP-3116475-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS Neuroderm Ltd (IL) 2017-01-18 EP claimed
US-20150352212-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM, LTD. (IL) 2015-12-10 US claimed
WO-2015136538-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2015-09-17 WO claimed
US-20260102334-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2026-04-16 US disclosed
US-20150352212-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM, LTD. (IL) 2015-12-10 US disclosed
WO-2015136538-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS NEURODERM LTD (IL) 2015-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230096364-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885
US-20210000777-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885
US-20170157079-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885
US-10813902-B2 DOPA decarboxylase inhibitor compositions DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885
US-20200046665-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885
US-20260102334-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS COMT, PARK7, DDT ALDH1A1 137/4885HPGD 78/4885ALOX15 1382/4885
US-10258585-B2 DOPA decarboxylase inhibitor compositions DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885
US-20250073193-A1 DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS DDT, DDC, COMT ALDH1A1 339/4885HPGD 372/4885ALOX15 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.